27
Active Signals
โฒ 4 new this week
12
Open Initiatives
โฒ 2 escalated
48
Tasks In Progress
โฒ 7 added today
+34%
Decision Accuracy
โฒ vs. baseline
98.2%
Inspection Readiness
โฒ 3.1pp this quarter
Continuous Intelligence Loop
Active
Sense
TrendIQ
27 signals active
CPVCAPAAPQR
Decide
DecisionIQ
12 initiatives active
ALCOA+ICH Q10
Execute
ActionIQ
48 tasks in flight
KanbanGantt
Learn
EffectivenessIQ
7 outcomes validated
CPVAPQR
โ Continuous loop active ยท ICH Q10 Aligned ยท ALCOA+ Compliant ยท Human-in-the-loop governance ON
Functional Area Performance
Q4 2024
Inspection Readiness Trend
Initiative Pipeline
| Initiative | Stage | Owner | Impact |
|---|---|---|---|
| CAPA Recurrence Reduction | DecisionIQ | Dr. Patel | Critical |
| CPV Trend Anomaly โ Line 3 | TrendIQ | M. Torres | High |
| APQR Data Integrity Gap | ActionIQ | K. Nguyen | High |
| Deviation Classification AI Model | EffectIQ | S. Okonkwo | Medium |
| Batch Review Standardization | ActionIQ | P. Chen | Medium |
Live Audit Trail
ALCOA+
Before / After โ Traditional QMS vs. IntelligenceIQ
ICH Q10 Aligned
Traditional QMS
๐ Event tracking only
๐ Reactive CAPA management
๐
Periodic APQR (annual)
๐ง Manual consistency via SMEs
IntelligenceIQ โ ICH Q10 Aligned
๐ง Knowledge management + continuous learning
๐ฏ Proactive CAPA with effectiveness validation
๐ก Continuous CPV feedback loop
๐ค System-guided, AI-assisted decisions
27
Active Signals
โฒ 4 new
6
High Impact
โผ Requires Action
11
Medium Impact
โ Monitoring
10
Low / Informational
โ Logged
Live Signal Feed
AI-detected ยท SME-validated ยท GMP-scoped
CAPA Recurrence Rate Elevation โ Sterile Fill Line
CRITICAL
Recurrence rate exceeded 18% threshold for 3 consecutive months. ICH Q10 effectiveness criteria not met.
Confidence
87%
CPV Out-of-Trend โ Particle Count Line 3
HIGH
7 consecutive batches showing upward trend in particle counts. CPV limit approaching 3ฯ control limit.
APQR โ Data Integrity Gap in QMS Documentation
MEDIUM
Missing attributable records in 12% of batch records Q3 APQR review. ALCOA+ compliance risk flagged.
Deviation Classification Inconsistency โ QA Teams A & B
MEDIUM
Cross-team classification variance at 23% for similar deviation types. SME calibration required.
Initiative Creation Panel
| Initiative | Impact | Owner | Status |
|---|---|---|---|
| CAPA Effectiveness Remediation | 9.2 | Dr. Patel | In DecisionIQ |
| CPV Line 3 Investigation | 8.7 | M. Torres | New |
| ALCOA+ Documentation Fix | 7.1 | K. Nguyen | In ActionIQ |
AI Owner Recommendation
87% confident
For: CAPA Effectiveness Remediation
RP
Dr. R. Patel
VP Quality Assurance ยท Site A
โธOwns GMP quality performance for Sterile Fill Line
โธPreviously led successful ICH Q10 remediation (2022)
โธCurrent workload: 62% capacity โ available
Signal Source Distribution
Active Initiatives
CAPA Effectiveness Remediation
IQ-2024-031 ยท Initiated from TRD-0042 ยท Owner: Dr. R. Patel
Impact: 9.2
ICH Q10
Objective
Reduce CAPA recurrence to <5% within 90 days. Achieve ICH Q10 effectiveness criteria.
Priority
CRITICAL
Timeline
90-day remediation. Review at Day 30, 60, 90.
Status
โก PLANNING
Task Planning โ AI Owner Recommendations
Ready for Team Assignment
All tasks defined
โธ5 tasks structured ยท 3 task owners AI-recommended ยท ICH Q10 review checklist attached
Initiative Kanban โ GMP Compliance 2024
Click initiative to expand task board
Open3
CPV Line 3 Investigation
โผ tasks
HighCPV
ALCOA+ Documentation Gap
โผ tasks
MediumAPQR
Batch Review Standardization
โผ tasks
Medium
In Progress4
CAPA Effectiveness Remediation
โผ tasks
Progress42%
CriticalICH Q10
Deviation Classification AI Model
โผ tasks
Progress67%
Inspection Readiness Protocol
โผ tasks
Progress85%
Change Control Backlog Clearance
โผ tasks
โ BLOCKED
Completed5
Annual APQR Submission
โผ tasks
โ Done
GMP Training Refresh โ Site B
โผ tasks
โ Done
QMS Audit Trail Validation
โผ tasks
โ Done
Gantt โ CAPA Effectiveness Remediation
IQ-2024-031 ยท 90-day programme ยท QA Excellence Team
Assigned Teams โ Active Initiatives
QA
QA Excellence Team โ Site A
Lead: Dr. R. Patel ยท 4 members
Decision Ref
IQ-2024-031
Priority
CRITICAL
SLA Target
45 days โ
Risk Class
High / GMP
MFG
Manufacturing QC Team
Lead: M. Torres ยท 6 members
Decision Ref
IQ-2024-032
Priority
HIGH
SLA Target
30 days
Risk Class
Medium / CPV
AI Agent Monitor โ Execution Intelligence
Monitoring Active
Execution Drift Detection
โธALERT: Root Cause Reclassification โ 3 days behind schedule. Delay probability: 71%
โธSME Calibration Workshop โ at risk. Awaiting QA sign-off. Recommend escalation to VP Quality.
โธEffectiveness Checkpoint Design โ on track. No corrective action required.
Resource Reallocation
โธRecommend: Reassign J. Liu (QA Lead, 40% available) to Root Cause Reclassification task
โธAutomation opportunity: Batch record ALCOA+ validation โ 60% automatable via QMS API integration
โธSimilar past initiative (IQ-2022-008): 45-day timeline โ reference process available
Recommended Workflow โ Root Cause Reclassification
Step 1 ยท Day 1โ3
Pull all recurring CAPA records from QMS โ filter by recurrence flag within 12 months
Step 2 ยท Day 4โ7
Apply AI-assisted root cause taxonomy classification (ICH Q10 / ISPE aligned categories)
Step 3 ยท Day 8โ10
SME validation review with QA Lead โ consensus classification with rationale capture
Step 4 ยท Day 11โ14
Compare re-classified data against historical baseline. Generate effectiveness readiness report.
-47%
Manual QA Effort
โฒ Improvement
+34%
Decision Accuracy
โฒ vs. baseline
91%
CAPA Effectiveness
โฒ from 64%
-40%
Review Cycle Time
โฒ Improvement
74
IQ Maturity Score
โฒ +12 this quarter
KPI Performance โ Initiative Outcomes
Q4 2024
| Initiative | Goal KPI | Actual KPI | Delta | Attribution |
|---|---|---|---|---|
| CAPA Effectiveness | <5% recurrence | 4.2% โ | -13.8pp | 94% |
| CPV Signal Detection | 3ฯ limit hold | 2.1ฯ โ | -0.9ฯ | 87% |
| APQR Data Integrity | 100% ALCOA+ | 96.3% | -3.7pp | 79% |
| Review Cycle Time | <3 days | 1.8 days โ | -1.2 days | 91% |
| Deviation Classification | <10% variance | 14.2% | +4.2pp above target | 63% |
Before / After Analysis
GMP Quality Outcomes
18%
CAPA Recurrence (Before)
โ
4.2%
CAPA Recurrence (After)
64%
CAPA Effectiveness Rate (Before)
โ
91%
CAPA Effectiveness Rate (After)
3.0 days
QA Review Cycle Time (Before)
โ
1.8 days
QA Review Cycle Time (After)
23%
Classification Variance (Before)
โ
14.2%
Classification Variance (After)
Human Feedback โ Learning Loop
Root Cause Analysis Quality
Annotation: AI correctly identified procedural gap as primary root cause
Team Assignment Recommendation
Strategy adjustment: Should consider cross-site team for multi-site CAPA patterns
AI Performance Metrics
Outcome Attribution
CAPA Effectiveness Remediation ยท IQ-2024-031
Root Cause Reclassification Task
71%
Effectiveness Checkpoint Design
19%
Cross-functional Retrospective
10%
Executive Value Summary
"IntelligenceIQ has transformed our GMP quality system into a continuous learning engine โ improving CAPA effectiveness, strengthening inspection readiness, and enabling consistent, defensible decision-making while maintaining full QA control."
$2.4M
Cost Avoidance
-31%
Audit Findings
98.2%
Inspection Ready
Learning Feedback Loop
Active
TrendIQOutcome data fed back โ CAPA signal sensitivity threshold adjusted from 18% โ 12%
DecisionIQModel weights updated โ root cause taxonomy confidence improved +8%
ActionIQTeam recommendation logic refined โ QA Excellence Team pattern confirmed for CAPA-type initiatives
EffectIQAI confidence baselines updated โ next cycle starts with 4.2% recurrence as new benchmark
14
Open CAPAs
โผ 3 overdue
8
Pending Effectiveness
โ 30/60/90 review
91%
Effectiveness Rate
โฒ from 64% baseline
4.2%
Recurrence Rate
โฒ below 5% target
CAPA Register โ Active & Pending
ICH Q10 ยท ALCOA+ Aligned ยท 30/60/90-Day Effectiveness Checkpoints
| CAPA ID | Description | Category | Root Cause | Owner | D30 | D60 | D90 | Status | AI Risk |
|---|---|---|---|---|---|---|---|---|---|
| CAPA-2024-041 | Sterile fill particulate deviation โ recurring | Recurring | Procedural gap | Dr. Patel | โ | Due | โ | In Progress | HIGH |
| CAPA-2024-038 | ALCOA+ documentation gaps โ batch records Q3 | Systemic | Training gap | K. Nguyen | โ | โ | Due | Verification | MED |
| CAPA-2024-031 | Deviation classification inconsistency QA Team A/B | Systematic | SME calibration | S. Okonkwo | โ | โ | โ | Closed | LOW |
| CAPA-2024-027 | OOS result โ API potency out of spec batch #BX-2291 | Critical | Equipment drift | M. Torres | โ | โ | โ | Closed | LOW |
| CAPA-2024-019 | Environmental monitoring excursion EM-Zone C | Recurring | Root cause TBD | P. Chen | Overdue | โ | โ | โ Overdue | CRITICAL |
| CAPA-2024-012 | Change control SOP deviation โ Line 2 upgrade | Systemic | Process gap | L. Rodriguez | Overdue | โ | โ | โ Overdue | HIGH |
AI CAPA Risk Monitor
Live
โธ2 CAPAs overdue โ escalation recommended to VP Quality
โธCAPA-2024-038 D90 checkpoint due in 3 days โ schedule verification review
โธOverall effectiveness rate 91% โ exceeds ICH Q10 target of 85%
โธRecurrence pattern: 67% of recurring CAPAs linked to campaign changeover period
Effectiveness Trend
CAPA by Root Cause Type
3
Out-of-Trend Parameters
โผ Action Required
7
Warning Zone
โ Monitor Closely
24
In Control
โฒ Within 2ฯ
34
Total CPV Parameters
โ Active monitoring
CPV Parameter Dashboard
Continuous Process Verification ยท ICH Q8/Q9/Q10 ยท Real-Time Signal Detection
| Parameter | Product / Line | Batches | Current ฯ | Trend | Limit | Status | Signal to TrendIQ |
|---|---|---|---|---|---|---|---|
| Particle Count (โฅ2ฮผm) | Sterile Fill ยท Line 3 | 7 consec. | 2.9ฯ | โโ | 3ฯ | โ OOT | |
| API Assay (%LC) | Oral Solid ยท Line 1 | 3 batches | 2.6ฯ | โ | 3ฯ | โ OOT | |
| Endotoxin (EU/mL) | Injectable ยท Line 5 | 2 batches | 2.4ฯ | โ | 3ฯ | โ OOT | |
| Dissolution Rate (Q30) | Oral Solid ยท Line 2 | 5 batches | 2.1ฯ | โโ | 3ฯ | Warning | |
| Water Activity (Aw) | Oral Solid ยท Line 1 | 4 batches | 1.9ฯ | โ | 3ฯ | Warning | |
| pH (Buffered Solution) | Injectable ยท Line 4 | 12 batches | 0.8ฯ | โ | 3ฯ | In Control | โ |
| Blend Uniformity (RSD%) | Oral Solid ยท Line 2 | 8 batches | 1.1ฯ | โ | 3ฯ | In Control | โ |
Control Chart โ Particle Count ยท Line 3
OOT Signal Active
โ UCL (3ฯ)
โ UWL (2ฯ)
โ Mean
โ LWL (2ฯ)
โ LCL (3ฯ)
AI CPV Signal Analysis
92% confident
โธParticle Count: 7-batch upward run โ Western Electric Rule 2 violated. Probable assignable cause.
โธCorrelation detected: particle count trend aligns with HVAC maintenance gap (Line 3, Weeks 38โ41)
โธHistorical match: similar pattern observed in 2022 Q2 โ root cause was filter replacement schedule slip
โธRecommended action: immediate filter integrity check + HVAC system inspection Line 3
Parameter Status Distribution
Line Performance Summary
3
APQR Reports Active
โ Current year
96.3%
Data Integrity Score
โฒ from 88%
47
Batches Reviewed
โ YTD 2024
2
Action Items Open
โผ Remediation needed
APQR Report Index
APQR-2024-A
In Progress
Sterile Injectables โ Annual Product Quality Review 2024
Due: Dec 31 2024 ยท Owner: Dr. Patel ยท 34 batches
APQR-2024-B
Action Required
Oral Solid Dosage โ Annual Product Quality Review 2024
Due: Nov 30 2024 ยท Owner: M. Torres ยท 13 batches ยท โ Data Integrity Flag
APQR-2023-A
Approved
Sterile Injectables โ Annual Product Quality Review 2023
Submitted: Jan 15 2024 ยท Approved: Feb 3 2024 ยท Regulatory ref: REG-2024-0031
APQR-2024-A โ Sterile Injectables
34 batches ยท JanโOct 2024 ยท ALCOA+ review in progress
Batch Yield
99.1%
Target: โฅ98%
OOS Rate
0.3%
Limit: <1%
CAPA Linked
4
2 open
Section Completion
AI APQR Insights
78% confident
โธAPQR-2024-B flag: 12% of batch records missing attributable signatures โ ALCOA+ 'A' criterion not met
โธAPQR-2024-A yield trending positive: 3 consecutive quarters above 99% โ process is stable
โธCPV trends in APQR-2024-A support continued annual review frequency โ no signal for enhanced review
โธRecommend CAPA-2024-038 be cited in APQR-2024-B Section 8 (CAPA effectiveness review)
6
Open Deviations
โผ 2 critical
3
Pending Classification
โ AI-assisted
14.2%
Classification Variance
โผ above 10% target
89
Closed YTD
โฒ Avg 2.1 days
Deviation Log
GMP Deviation Management ยท AI-Assisted Classification ยท ALCOA+ Compliant
| Dev ID | Description | Area | Severity | AI Classification | SME Override | CAPA Linked | Status | Action |
|---|---|---|---|---|---|---|---|---|
| DEV-2024-187 | Sterile fill line stoppage โ gowning breach SOP-QA-011 | Sterile Fill | Major | Procedural ยท 89% | โ | CAPA-2024-041 | Investigation | |
| DEV-2024-183 | Batch BX-3412 โ vial visual inspection reject rate 1.8% vs 1.5% limit | QC Inspection | Minor | Equipment ยท 76% | Changed โ Process | Pending | Pending Class. | |
| DEV-2024-179 | EM excursion EM-Zone C โ Mold/yeast count 3ร alert limit | EM Monitoring | Critical | Environmental ยท 94% | โ | CAPA-2024-019 | โ Escalated | |
| DEV-2024-171 | Documentation error โ missing date on manufacturing record line 47 | Documentation | Minor | Human Error ยท 91% | โ | None | Open | |
| DEV-2024-158 | OOS confirmed โ API potency batch BX-2291 (2.1% below spec) | QC Laboratory | Major | Equipment ยท 88% | โ | CAPA-2024-027 | Closed | Closed |
| DEV-2024-144 | Blend time deviation โ granulation step 12% over validated range | Manufacturing | Minor | Pending ยท โ | โ | None | Pending Class. |
AI Classification Engine
Active
โธDEV-2024-183: SME override recorded โ AI model flagged for retraining (HumanโEquipment vs Process)
โธVariance alert: Classification variance at 14.2% โ above 10% ICH Q10 target. SME calibration recommended.
โธDEV-2024-144 pending โ initial analysis: Equipment category (blend time sensor drift) โ 73% confidence
Deviation by Category
Monthly Deviation Trend